MTOR and hepatocellular carcinoma: In xenograft models, the treatment of rapamycin enriched the population of CD133+ cells and promoted tumorigenesis of HCC cells.142 Altogether, the data from several groups suggested the dual role of mTOR signaling in cancer stem cells in human malignancies.